Target intelligence / Profile preview

Myosin-2 (Myosin II / NM2)

Target
Myosin II / NM2
Molecular classification
Enzyme, Actin-based motor protein, ATPase
01

Overview

Myosin-2 is a large molecular motor protein composed of two heavy chains (approximately 2000 amino acids each) that forms the major structural component of muscle thick filaments and drives force generation in both muscle and nonmuscle cells[1][7]. The protein converts energy from ATP hydrolysis into mechanical force through cyclic interactions with actin filaments, with its structure consisting of N-terminal head domains (the motor unit) connected to long α-helical coiled-coil tail domains that mediate protein assembly[1][3]. Myosin-2 exists in multiple isoforms—including cardiac, skeletal, smooth muscle, and nonmuscle variants—each with specialized regulatory mechanisms suited to their tissue type[2]. The protein is regulated through phosphorylation of its regulatory light chains and through interactions with accessory proteins such as myosin-binding protein C, which modulates cardiac contractility[1][5]. Mutations in myosin-2, particularly in the coiled-coil S2 region, are associated with familial hypertrophic cardiomyopathy, a leading cause of sudden cardiac death[1]. The structural flexibility of the S2 subfragment is critical for both force generation and regulation, making it an important region for understanding both normal muscle physiology and disease pathogenesis[1][3].

Other names
Myosin IIClass-2 myosinNonmuscle myosin-2 (NM2)Smooth muscle myosin-2Cardiac myosin-2Skeletal myosin-2
02

Mechanism of action

ATP hydrolysis-dependent cyclic interaction with actin filaments to produce force\nConformational changes in the motor domain driven by ATPase activity\nRegulation through phosphorylation of regulatory light chains (RLC) in the autoinhibited 10S state\nRegulation through myosin-binding protein C interactions in cardiac muscle

03

Biological functions

Muscle contraction (cardiac, skeletal, and smooth muscle)Actin-based motility and force generationCell movement and shape change in nonmuscle cellsATP-dependent molecular motor activityThick filament assembly and organization
04

Disease associations

Cardiovascular disease (familial hypertrophic cardiomyopathy/HCM)Muscle dysfunction and contractility disordersCellular dysfunction in conditions requiring force generation and cell movement
05

Safety considerations

Disease-associated mutations affecting charge interactions in the S2 subfragment can lead to familial hypertrophic cardiomyopathyGenetic variants affecting myosin-binding protein C interactions may compromise cardiac functionPotential for off-target effects on muscle contraction if therapeutic interventions are not muscle-type specific
06

Biomarkers

Phosphorylation status of regulatory light chain (RLC), particularly S19 phosphorylation, which controls autoinhibition and activationDisease-associated mutations (e.g., E924K in cardiac myosin-2 associated with familial hypertrophic cardiomyopathy)

Beyond the preview

Go deeper on Myosin-2 (Myosin II / NM2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Myosin-2 (Myosin II / NM2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call